Ascentage Pharma Group International (FRA:36X)

FRA:36X Revenue

Ascentage Pharma Group International had revenue of 233.70M CNY in the half year ending June 30, 2025, with 63.77% growth. This brings the company's revenue in the last twelve months to 390.60M, down -56.75% year-over-year. In the year 2024, Ascentage Pharma Group International had annual revenue of 980.65M with 341.77% growth.

• Revenue (ttm): 390.60M CNY
• Revenue Growth: -56.75%
• P/S Ratio: 55.63
• Revenue / Employee: 688.89K CNY
• Employees: 567
• Market Cap: 2.58B EUR

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	980.65M	758.67M	341.77%
Dec 31, 2023	221.98M	12.27M	5.85%
Dec 31, 2022	209.71M	181.80M	651.38%
Dec 31, 2021	27.91M	15.46M	124.18%
Dec 31, 2020	12.45M	-2.06M	-14.21%